Clinical Trial Update: A Study to Evaluate Add on Effect of Solifenacin in Men With Overactive Bladder Symptoms After Tamsulosin Monotherapy for 4 Weeks [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating the added benefit of solifenacin in men with overactive bladder after initial tamsulosin therapy; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Vesicare (solifenacin succinate)

Snippet

Sponsor: KYU-SUNG LEE | Conditions: Overactive Bladder | Phase 4 | Status: COMPLETED